Integer Holdings Co. (NYSE:ITGR - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $145.56.
Several research analysts recently weighed in on the company. Truist Financial set a $150.00 price target on Integer and gave the company a "buy" rating in a research report on Friday, April 25th. KeyCorp dropped their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Benchmark cut their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. StockNews.com cut Integer from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Finally, Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st.
Get Our Latest Report on ITGR
Insider Activity at Integer
In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.16% of the company's stock.
Institutional Trading of Integer
Hedge funds and other institutional investors have recently made changes to their positions in the company. Mather Group LLC. raised its position in Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. purchased a new stake in Integer in the 4th quarter valued at about $27,000. AdvisorNet Financial Inc purchased a new position in Integer during the first quarter worth about $28,000. Opal Wealth Advisors LLC acquired a new stake in shares of Integer during the first quarter valued at about $28,000. Finally, Bessemer Group Inc. raised its stake in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 125 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.
Integer Stock Performance
NYSE:ITGR traded up $1.65 during midday trading on Thursday, hitting $118.20. The company's stock had a trading volume of 1,069,826 shares, compared to its average volume of 359,790. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The firm's 50 day moving average is $118.53 and its 200-day moving average is $129.91. The firm has a market cap of $4.12 billion, a P/E ratio of 35.18, a P/E/G ratio of 1.72 and a beta of 1.03.
Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same quarter last year, the company posted $1.14 earnings per share. The firm's revenue was up 7.3% compared to the same quarter last year. Equities analysts anticipate that Integer will post 6.01 earnings per share for the current fiscal year.
About Integer
(
Get Free ReportInteger Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also

Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.